Stock Track | XTALPI Soars 5.04% in Intraday Trading on AI Platform Launch and Broker Upgrades

Stock Track09:38

XTALPI (02228) surged 5.04% in intraday trading on Tuesday, extending its strong momentum from the previous session. The rally reflects growing investor optimism around the company's strategic shift toward an AI-driven platform model.

The stock got a boost after the company recently launched its XtalPi Science intelligent platform and co-initiated the "Scientific Intelligence Open Ecosystem Alliance" with 26 institutions. Market expectations are rising for a valuation re-rating as XTALPI transitions from a traditional CRO service provider to an AI platform company. Additionally, JP Morgan initiated coverage with an "Overweight" rating, while Zheshang Securities maintained a "Buy" rating, highlighting that core business revenue grew 65% year-over-year after stripping out a one-time pipeline payment.

The broader Life Sciences Tools & Services sector also strengthened, with peers like PHARMARON and INSILICO advancing, reflecting continued capital inflows into the AI-driven drug discovery theme. Ahead of its board meeting on August 19 to review interim results, the stock has garnered additional attention from investors positioning for the upcoming earnings window.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1178996562?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-11 09:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1178996562","market":"nz","top_or_hot":-1,"title":"Stock Track | XTALPI Soars 5.04% in Intraday Trading on AI Platform Launch and Broker Upgrades","media":"Stock Track","content":"<p>XTALPI (02228) surged 5.04% in intraday trading on Tuesday, extending its strong momentum from the previous session. The rally reflects growing investor optimism around the company's strategic shift toward an AI-driven platform model.</p><p>The stock got a boost after the company recently launched its XtalPi Science intelligent platform and co-initiated the \"Scientific Intelligence Open Ecosystem Alliance\" with 26 institutions. Market expectations are rising for a valuation re-rating as XTALPI transitions from a traditional CRO service provider to an AI platform company. Additionally, JP Morgan initiated coverage with an \"Overweight\" rating, while Zheshang Securities maintained a \"Buy\" rating, highlighting that core business revenue grew 65% year-over-year after stripping out a one-time pipeline payment.</p><p>The broader Life Sciences Tools & Services sector also strengthened, with peers like PHARMARON and INSILICO advancing, reflecting continued capital inflows into the AI-driven drug discovery theme. Ahead of its board meeting on August 19 to review interim results, the stock has garnered additional attention from investors positioning for the upcoming earnings window.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | XTALPI Soars 5.04% in Intraday Trading on AI Platform Launch and Broker Upgrades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | XTALPI Soars 5.04% in Intraday Trading on AI Platform Launch and Broker Upgrades\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-08-11 09:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>XTALPI (02228) surged 5.04% in intraday trading on Tuesday, extending its strong momentum from the previous session. The rally reflects growing investor optimism around the company's strategic shift toward an AI-driven platform model.</p><p>The stock got a boost after the company recently launched its XtalPi Science intelligent platform and co-initiated the \"Scientific Intelligence Open Ecosystem Alliance\" with 26 institutions. Market expectations are rising for a valuation re-rating as XTALPI transitions from a traditional CRO service provider to an AI platform company. Additionally, JP Morgan initiated coverage with an \"Overweight\" rating, while Zheshang Securities maintained a \"Buy\" rating, highlighting that core business revenue grew 65% year-over-year after stripping out a one-time pipeline payment.</p><p>The broader Life Sciences Tools & Services sector also strengthened, with peers like PHARMARON and INSILICO advancing, reflecting continued capital inflows into the AI-driven drug discovery theme. Ahead of its board meeting on August 19 to review interim results, the stock has garnered additional attention from investors positioning for the upcoming earnings window.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02228","symbol_name":"晶泰控股","start_time":0,"source_url":"","article_id":"1178996562","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1178996562","pubTimestamp":1786412305,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"XTALPI (02228) surged 5.04% in intraday trading on Tuesday, extending its strong momentum from the previous session. The rally reflects growing investor optimism around the company's strategic shift...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02228":"晶泰控股"},"translate_title":"股票跟踪|XTALPI在人工智能平台推出和经纪商升级的日内交易中飙升5.04%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02228":1},"content_text":"XTALPI (02228) surged 5.04% in intraday trading on Tuesday, extending its strong momentum from the previous session. The rally reflects growing investor optimism around the company's strategic shift toward an AI-driven platform model.The stock got a boost after the company recently launched its XtalPi Science intelligent platform and co-initiated the \"Scientific Intelligence Open Ecosystem Alliance\" with 26 institutions. Market expectations are rising for a valuation re-rating as XTALPI transitions from a traditional CRO service provider to an AI platform company. Additionally, JP Morgan initiated coverage with an \"Overweight\" rating, while Zheshang Securities maintained a \"Buy\" rating, highlighting that core business revenue grew 65% year-over-year after stripping out a one-time pipeline payment.The broader Life Sciences Tools & Services sector also strengthened, with peers like PHARMARON and INSILICO advancing, reflecting continued capital inflows into the AI-driven drug discovery theme. Ahead of its board meeting on August 19 to review interim results, the stock has garnered additional attention from investors positioning for the upcoming earnings window.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1178996562","isCrawlerRequest":true}